posted
I'm still trying to learn how to tell what the resistance # are. Does someone have a # in mind for this one.
Posts: 49 | From: Texas | Registered: Jul 2009
| IP: Logged |
posted
Hope this junk gets to .003 FAST and I'm out! I'm bleeding badly today all over- except GERS
Posts: 2793 | From: Coral Springs, FL, USA | Registered: Aug 2003
| IP: Logged |
posted
Hello Love the Market. You are not alone. I am bleeding all over today. I guess I'll do nothing today except watch them. I will lose no money unless I sell anything at a lower route....if you know what I mean.
Posts: 602 | From: Minneapolis | Registered: Jul 2009
| IP: Logged |
posted
Hey bud - I can't believe what's happened in the past week with this, SALN, OMHI, OPGX , BWNR, IDOI and all my other losers! It's like: "Let's get Steve week"! Oh well - looks like I need two or three more ATNO comebacks to get out even or with a little $$.
What do you think the KKUR news will do - if anything? So far it's only .0017 - I had my sell in for .0034 ALMOST got it last week - oh well.
Good Luck!
Posts: 2793 | From: Coral Springs, FL, USA | Registered: Aug 2003
| IP: Logged |
posted
KKUR will get to your target imo. A great news release of progress or something will land us there imo.
Do nothing with OPGX, I saw a very heavy volume yesterday...(Accummulation), but there was no movement. It will fly shortly to a higher level. imo
Posts: 602 | From: Minneapolis | Registered: Jul 2009
| IP: Logged |
At least we're here to play the game - we must thank God for that! For me - this is my desktop casino - WITHOUT leaving home! (Takes a little bit longer to lose too, compared to Black-Jack! And sometimes we get lucky and hit a grand slam... (NOT too Often though)!
Good Luck to us all. Steve
Posts: 2793 | From: Coral Springs, FL, USA | Registered: Aug 2003
| IP: Logged |
ChromoCure, Inc. Launches Nationwide Diagnostic Lab Partnership Program
RENO, NV -- (Marketwire) -- 11/03/09 -- ChromoCure, Inc. (PINKSHEETS: KKUR) announced its partnership program for cancer diagnostic laboratories and research centers.
Industry pathologists and cancer diagnostic research centers may request the company's partnership package and materials at:
Pathology labs will receive ChromoCure's CS200 Chromosomal Scanner installed on their premises without cost. ChromoCure will provide training, material, and marketing guidance. Established insurance codes exist for ease of billing and collections. The ChromoCure CS200 can deliver immediate revenue to pathologists.
Cancer research centers may purchase the company's equipment or use one of the company's network pathology labs to perform chromosomal scans.
Preferred pricing will be extended to all cancer research partners.
Purchasers of the CS200 chromosomal scanner will receive a favorable upgrade price to the CS300 series when released.
The company has established this special program to expand it network of pathology labs as well as promote its science and technology with cancer research centers.
About ChromoCure
ChromoCure develops and provides proprietary cancer detection systems. The Company owns its technology and provides its systems on a revenue sharing basis. The Company's systems measure the unique genomic characteristic found in 100% of all cancers and never found in normal cells. The Company believes its technology has an effective accuracy of 100% for all cancers at all stages. The Company believes its technology superior and will become the gold standard for cancer detection worldwide.
The Company's technology and understanding of cancer also suggest non-toxic and non-invasive approaches to cancer therapy and cure research. The Company will release progress reports on these initiatives from time to time.
Safe-Harbor Statement
This release contains statements or projections regarding future performance that are forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995. Actual results may differ materially from those projected as a result of certain risks and uncertainties. The company's filings contain various RISK FACTORS (and are incorporated herein by reference) and should be read before any investment decision.
Investor Relations:
Contact:
ChromoCure, Inc.
info@chromocure.com
Tel 1.775.636.6548
Posts: 2793 | From: Coral Springs, FL, USA | Registered: Aug 2003
| IP: Logged |
"At least we're here to play the game - we must thank God for that! For me - this is my desktop casino - WITHOUT leaving home! (Takes a little bit longer to lose too, compared to Black-Jack! And sometimes we get lucky and hit a grand slam... (NOT too Often though)!"
_________________________________________________
I like that one!
But there(casino) you can kick the table or video poker machine and usually the worst you get is to be thrown out.
If you do that to your computor while playing the pennies, we have to pay to replace the computer and then cannot get a new one in time to catch that big bounce in our stocks.
Posts: 3875 | From: ca. | Registered: Jul 2005
| IP: Logged |
posted
I sure hope this gaps up or runs a little - I'll sell near or right after just to get out - Too diluted to move up to even .002 imho.
They call THIS News??? I think they did the same crap a few montha ago.....
Looking For Shareholder Opinions On ChromoCure's Latest News Looking For Shareholder Opinions On ChromoCure's Latest News Nov. 4, 2009 (M2 Communications Ltd.) --
www.PinnacleDigest.com is a performance-driven online financial magazine and social network with a proven track record. After yesterday's news from ChromoCure, Inc. (PINKSHEETS: KKUR) announcing its partnership program for cancer diagnostic laboratories and research centers, our team is inviting all shareholders to their exclusive investor controlled forum. Our staff and members have requested that all ChromoCure shareholders join our community and share their thoughts on the company, its development and future outlook. One of the most important aspects when we research for new investments is to understand the sentiment of the current shareholders; that is why we have released this announcement - we want to know your opinion.
Find out if ChromoCure makes it as a Pinnacle Featured Company,
Chat with other shareholders invested in ChromoCure,
Explain to our investor community what differentiates this company,
Connect with investors and professionals in the equity markets,
Meet the thousands of investors who have already become members of the Pinnacle community.
PinnacleDigest.com is an investment club comprised of over 15,000 members. We use all of our member's insight when selecting our next investment opportunity. Your membership is free - join today.
PinnacleDigest.com has no vested interest in the company mentioned herein. The company mentioned in this release has not compensated PinnacleDigest.com in any form to disseminate this release.
This source of information is from an unbiased perspective. If you wish to become a member of www.pinnacledigest.com you will be gaining access to articles similar to this one and many other useful services we know you will find valuable. Keeping you educated and up-to-date with the market is one of our main purposes. Our approach in achieving this goal and our ability to consistently deliver high quality investment material is what defines our business model.
This news release shall not constitute an offer to sell or the solicitation of any offer to buy securities in any jurisdiction.
All material herein was prepared by Pinnacledigest.com (Pinnacle Digest) based upon information believed to be reliable. The information contained herein is not guaranteed by Pinnacledigest.com to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Pinnacledigest.com is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein. Pinnacledigest.com may receive compensation in cash or shares from independent third parties or from the companies mentioned.
Pinnacledigest.com will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.
THE READER SHOULD VERIFY ALL CLAIMS AND DO THEIR OWN DUE DILIGENCE BEFORE INVESTING IN ANY SECURITIES MENTIONED. INVESTING IN SECURITIES IS SPECULATIVE AND CARRIES A HIGH DEGREE OF RISK.
This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies' annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission.
You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and Pinnacledigest.com undertakes no obligation to update such statements.
(Comments on this story may be sent to tww.feedback@m2.com)
Source: M2 Presswire (November 4, 2009 - 4:47 AM EST)
posted
I got some more to average down (In at .0022 for months)I have buy in for 1 mil at .0004 - only got 190580 filled yesterday....Order still open for almost 810,000. Good Luck.
Posts: 2793 | From: Coral Springs, FL, USA | Registered: Aug 2003
| IP: Logged |
posted
It's expected to show some strenght this month, but still waiting. I looked at HESG last week and picked up some shares at 0.0003 and today, it's high was 0.0009. and currently the asking is now at 0.0007.
Posts: 602 | From: Minneapolis | Registered: Jul 2009
| IP: Logged |
(OTC:KKUR) on the Front Line of Cancer Detection Note to Editor, the following is an investment opinion issued by the IO News Wire
NEW YORK, NY--(Marketwire)--November 19th, 2009, ChromoCure, Inc. (OTC:KKUR-NEWS) announced recently its nationwide diagnostic lab partnership program to increase awareness of its CS200 Chromosomal Scanner, its leading cancer detection system.
ChromoCure's research demonstrates and confirms the 100% common chromosomal condition present in every form of cancer. By detecting this unique chromosomal condition the Company’s ability to detect cancer, of all types and stages, is effectively 100% accurate. ChromoCure indicates they have the ability to completely eliminate false positives and false negatives for the presence of cancer.
ChromoCure believes it CS200 Chromosomal Scanner employs the most fastest, most accurate method of detecting cancer in tissue samples by testing for cancer’s unique chromosomal imbalance. The company’s research and scientific literature both support this imbalance as most accurate predictor of cancer available in today's market. The company does not believe any cancer technology exists that uses cancer’s unique chromosomal condition combined with automated cell nucleus scanning.
ChromoCure is positioning itself in the $16.8 billion dollar cancer detection and therapy market by offering its CS200 Chromosomal Scanner and soon to be released CS300 Scanner free to all participating pathology labs along with training, materials and marketing guidance.
The Company also has certain initiatives underway to apply its understanding of cancer to both therapeutic technologies and possible cure.
Other active stocks are Biocentric Energy Holdings (OTC:BEHL) Hologic (NASDAQ:HOLX) C.R. Bard, Inc (NYSE:BCR)
Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. A third party has hired and paid IO News Wire twelve hundred and ninety five dollars for the publication and circulation of this news release. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. We have no ownership of equity, no representation; do no trading of any kind and send No Faxes or emails.
posted
I am still waiting for KKUR. The above news produced about 0.0002 upward change last friday and same thing today before it finally closed at 0.0006. One of thses days we shall recoop.There will be more activities this month and early December according to rumur, so continue to keep your eyes on it.
Posts: 602 | From: Minneapolis | Registered: Jul 2009
| IP: Logged |
UBBFriend: Email this page to someone!
Printer-friendly view of this topic
![[BadOne]](graemlins/headbash.gif)
can only wait i guess ??
